Remote delivery of raav-gfp to the rat brainstem through the recurrent laryngeal nerve

Laryngoscope

Volumn 111, Issue 11, 2001, Pages 2041-2045

  Rubin, Adam D ^a   Hogikyan, Norman D ^a   Sullivan, Kelli ^b   Boulis, Nicholas ^b   Feldman, Eva L ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adeno associated virus; Gene therapy; Nucleus ambiguus; Recurrent laryngeal nerve; Retrograde transport

Indexed keywords

COMPLEMENTARY DNA; FLUOROGOLD; GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; AMBIGUUS NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; FROZEN SECTION; GENE TARGETING; HEPATITIS VIRUS; MEDULLA OBLONGATA; NONHUMAN; POLYSOME; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECURRENT LARYNGEAL NERVE; VIRUS RECOMBINANT;

ANIMALS; BRAIN STEM; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPATITIS B VIRUS, WOODCHUCK; IN SITU HYBRIDIZATION, FLUORESCENCE; INDICATORS AND REAGENTS; LUMINESCENT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECURRENT LARYNGEAL NERVE;

EID: 0034762103     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-200111000-00032     Document Type: Article

References (26)

1. Eisele D. Complications of thyroid surgery. In; Eisele D, ed. Complications in Head and Neck Surgery. St. Louis; Mosby-Year Book, 2000; 423-437.
2. Netterville JL, Aly A, Ossoff RH. Evaluation and treatment of complications of thyroid and parathyroid surgery. Otolaryngol Clin North Am 1990; 23; 529-552.
3. Goding GS Jr. Nerve-muscle pedicle reinnervation of the paralyzed vocal cord. Otolaryngol Clin North Am 1991; 24; 1239-1252.
4. Horn KL, Crumley RL. The physiology of nerve injury and repair. Otolaryngol Clin North Am 1984; 17; 321-333.
5. Jacobs IN, Sanders I, Wu BL, Biller HF. Reinnervation of the canine posterior cricoarytenoid muscle with sympathetic preganglionic neurons. Ann Otol Rhinol Laryngol 1990; 99; 167-174.
6. Singleton JR, Dixit VM, Feldman EL. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J Biol Chem 1996; 271; 31791-31794.
7. Kim B, Leventhal PS, Saltiel AR, Feldman EL. Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires MAP kinase activation. J Biol Chem 1997; 272; 21268-21273.
8. Russell JW, Windebank AJ, Schenone A, Feldman EL. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. J Neurobiol 1998; 36; 455-467.
9. Baumgartner BJ, Shine HD. Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J Neurosci 1997; 17; 6504-6511.
10. Gimenez Y, Ribotta M, Revah F, et al. Prevention of motorneuron death by adenovirus-mediated neurotrophic factors. J Neurosci Res 1997; 48; 281-285.
11. Lewin GR. Neurotrophic factors and pain. Semin Neurosci 1995; 7; 227-232.
12. Dittrich FH, Thoenen H, Sendtner M. Ciliary neurotrophic factor; pharmacokinetics and acute-phase response in rat. Ann Neurol 1994; 35; 151-163.
13. Kang UJ. Genetic modification of cells with retrovirus vectors for grafting into the central nervous system. In; Kaplitt MG, Loewy AD, eds. Viral Vectors; Gene Therapy and Neuroscience Applications. San Diego; Academic Press, 1995; 211-237.
14. Nakahara Y, Gage FH, Tuszynski MH. Grafts of fibroblasts genetically modified to secrete NGF, BDNF, NT-3, or bFGF elicit differential responses in the adult spinal cord. Cell Transplant 1996; 5; 191-204.
15. Tuszynski MH, Murai K, Blesch A, Grill R, Miller I. Functional characterization of NGF-secreting cell grafts to the acutely injured spinal cord. Cell Transplant 1997; 6; 361-368.
16. Boulis NM, Bhatia V, Brindle TI, et al. Adenoviral nerve growth factor and β-galactosidase transfer to spinal cord; a behavioral and histological analysis. J Neurosurg (Spine 1) 1998; 90; 99-108.
17. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 1993; 3; 219-223.
18. Boulis NM, Turner DE, Dice JA, Bhatia V, Feldman EL. Characterization of adenoviral gene expression in spinal cord after remote vector delivery. Neurosurgery 1999; 45; 131-138.
19. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York; Academic Press, 1982.
20. Schmued LC, Fallon JH. Fluoro-Gold; a new fluorescent retrograde axonal tracer with numerous unique properties. Brain Res 1986; 377; 147-154.
21. Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996; 70; 8098-8108.
22. Xiao X, Li J, McCown TJ, Samulski RJ. Gene transfer by adeno-associated virus vectors into the central nervous system. Exp Neurol 1999; 144; 113-124.
23. Boulis NM, Noordmans AJ, Feldman EL, Imperiale MJ. Adeno-associated viral gene expression in the adult rat spinal cord following remote vector delivery. Molecular Therapy-The Journal of the American Society of Gene Therapy. Abstracts from the third Annual Meeting of the American Society of Gene Therapy, May 31-June 4, 2000.
24. Liu Y, Himes BT, Moul J, et al. Application of recombinant adenovirus for in vivo gene delivery to spinal cord. Brain Res 1997; 768; 19-29.
25. Ghadge GD, Roos RP, Kang UJ, et al. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther 1995; 2; 132-137.
26. Shiotani A, O’Malley BW Jr., Coleman ME, Flint PW. Human insulinlike growth factor 1 gene transfer into paralyzed rat larynx; single vs multiple injection. Arch Otolaryngol Head Neck Surg 1999; 125; 555-560